IRCCS Sacro Cuore Don Calabria

IRCCS Sacro Cuore Don Calabria

uitklapper, klik om te openen

Partner Information uitklapper, klik om te openen

The IRCCS Sacro Cuore Don Calabria Hospital (IRCCSDC) is a Classified Private Hospital. The hospital has a status equivalent to public health structures, with an efficient, high-quality health care system. IRCCSDC has 18 certified divisions with around 500 beds and 1,840 employees

The departments involved in STOPSTORM are the Department of Cardiology and the Advanced Radiation Oncology Department. IRCCSDC allows for a close relationship between cardiologists and  radiation oncologists, and there will be close collaboration during STOPSTORM.

The Cardiology Department provides high quality healthcare and offers outpatient service, hospital ward and interventional cardiology/electrophysiology rooms. is deeply experienced in the diagnosis, prevention and treatment of cardiac arrhythmias; particularly the ICD/PM/CRT implantation and arrhythmic substrates ablations are currently performed to protect patients from VTs and to prevent sudden cardiac death.

The Radiotherapy Department has high technology equipment and physicians with a huge experience in radiation oncological and stereotactic ablative radiation treatments. The available MR-Linac allows an adaptive radiation approach and a high precision radiation treatment.

Personnel uitklapper, klik om te openen

Dr. Giulio Molon

Dr. Giulio Molon is the Director of Cardiology Unit and his research activities focus on clinical arrhytmology. Since 2014, he is included in the list of Experts of the European Community and from January 2019 he has performed the role of Reviewer within Horizon 2020 project RITMOCORE. He is the co-author of the Application “MyPacemaker”, designed for i-Phone for patients with Pace-Maker and ICD/CRT, and available worldwide.


Prof. Dr. Filippo Alongi

Prof. Dr. Filippo Alongi is Associate Professor and the IRCCSDC Director of Department of Advanced Radiation Oncology. He has published over 220 articles and leads a research line focusing on MR images and MR-Linac development, intra and extracranial ablative radiation treatments. He is principal investigator in several clinical studies including MR-Linac. He is the currently reviewer for EORTC protocol and Coordinator of Oligometastatic group at Associazione Italiana di Radioterapia Oncologica (AIRO). In STOPSTORM Prof. Alongi will support the enrolment of patients for STAR, and the preparation of ablative radiation treatments.

Dr. Niccolò Giaj-Levra, PhD

Dr. Niccolò Giaj-Levra, PhD is a radiation oncologist at IRCCSDC and he has developed clinical studies about MR-Linac and MR-images, stereotactic radiotherapy treatment, oligometastases, IGRT, and development of immobilization device, and is also co-investigator in several clinical trials. He is a member of EORTC Lung Cancer Group as a young investigator, and coordinator of Central Nervous System Disease at AIRO. In STOPSTORM Dr. Giaj-Levra will support patient enrolment and  preparation of the ablative radiation treatments.

Publications uitklapper, klik om te openen

  1. Ahmed N, Perveen S, Mehmood A, et al. Coronary sinus ablation is a key player substrate in recurrence of persistent atrial fibrillation. Cardiology 2019; 143: 107-113.
  2. Landolina M, Arena G, Iacopino S, et al. Center experience does not influence long-term outcome and peri-procedural complications after cryoballoon ablation of paroxysmal atrial fibrillation: Data on 860 patients from the real-world multicenter observational project. Int J Cardiol 2018; 272: 130-6.
  3. Mazzola R, Ruggieri R, Figlia V, et al. Stereotactic body radiotherapy of central lung malignancies using a simultaneous integrated protection approach: A prospective observational study. Strahlenther Onkol 2019; 195: 719-24.
  4. Trovo M, Furlan C, Polesel J, et al. Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial. Radiother Oncol 2018; 126: 177-80.


EU flag

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 945119. Follow us on Twitter and Linkedin.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

This website uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not